PT2221309E - Derivado de naftiridina sob a forma de mono-hidrato e processo para o seu fabrico - Google Patents

Derivado de naftiridina sob a forma de mono-hidrato e processo para o seu fabrico

Info

Publication number
PT2221309E
PT2221309E PT88552864T PT08855286T PT2221309E PT 2221309 E PT2221309 E PT 2221309E PT 88552864 T PT88552864 T PT 88552864T PT 08855286 T PT08855286 T PT 08855286T PT 2221309 E PT2221309 E PT 2221309E
Authority
PT
Portugal
Prior art keywords
producing
monohydrate
same
naphthyridine derivative
dioxino
Prior art date
Application number
PT88552864T
Other languages
English (en)
Inventor
Yasutaka Baba
Taro Kiyoto
Masahiro Takebayashi
Muneo Syoji
Toshiya Noguchi
Fumihito Ushiyama
Hiroki Urabe
Hiromasa Horikiri
Original Assignee
Toyama Chemical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toyama Chemical Co Ltd filed Critical Toyama Chemical Co Ltd
Publication of PT2221309E publication Critical patent/PT2221309E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/34—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D309/36—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms
    • C07D309/40—Oxygen atoms attached in positions 3 and 4, e.g. maltol
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pyrane Compounds (AREA)
PT88552864T 2007-11-26 2008-11-25 Derivado de naftiridina sob a forma de mono-hidrato e processo para o seu fabrico PT2221309E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2007304736 2007-11-26

Publications (1)

Publication Number Publication Date
PT2221309E true PT2221309E (pt) 2013-10-01

Family

ID=40678484

Family Applications (1)

Application Number Title Priority Date Filing Date
PT88552864T PT2221309E (pt) 2007-11-26 2008-11-25 Derivado de naftiridina sob a forma de mono-hidrato e processo para o seu fabrico

Country Status (21)

Country Link
US (1) US8354426B2 (pt)
EP (1) EP2221309B1 (pt)
JP (1) JP5491195B2 (pt)
KR (1) KR20100088693A (pt)
CN (1) CN101874032B (pt)
AU (1) AU2008330725B2 (pt)
BR (1) BRPI0820394A2 (pt)
CA (1) CA2706929A1 (pt)
CY (1) CY1114936T1 (pt)
DK (1) DK2221309T3 (pt)
ES (1) ES2426593T3 (pt)
HK (1) HK1145179A1 (pt)
HR (1) HRP20130860T1 (pt)
IL (1) IL205849A0 (pt)
MX (1) MX2010005725A (pt)
NZ (1) NZ585529A (pt)
PL (1) PL2221309T3 (pt)
PT (1) PT2221309E (pt)
SI (1) SI2221309T1 (pt)
WO (1) WO2009069589A1 (pt)
ZA (1) ZA201003507B (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8329694B2 (en) 2005-06-24 2012-12-11 Toyama Chemical Co., Ltd. Quinoxalinones as antibacterial composition
NZ573032A (en) 2006-05-26 2010-12-24 Taisho Pharmaceutical Co Ltd Antimicrobial heretocyclic compound and intermediates for its production
NZ593891A (en) 2008-12-12 2013-05-31 Actelion Pharmaceuticals Ltd 5-amino-2-(1-hydroxy-ethyl)-tetrahydropyran derivatives
US9029368B2 (en) 2011-11-30 2015-05-12 Actelion Pharmaceuticals Ltd. 3,7-disubstituted octahydro-2H-pyrido[4,3-E][1,3]oxazin-2-one antibiotics
US9863798B2 (en) 2015-02-27 2018-01-09 Schneider Electric Systems Usa, Inc. Systems and methods for multiphase flow metering accounting for dissolved gas

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4370002B2 (ja) 1997-08-08 2009-11-25 富山化学工業株式会社 キノロンカルボン酸誘導体またはその塩
GB0031088D0 (en) 2000-12-20 2001-01-31 Smithkline Beecham Plc Medicaments
GB0101577D0 (en) 2001-01-22 2001-03-07 Smithkline Beecham Plc Compounds
TW200409637A (en) 2002-06-26 2004-06-16 Glaxo Group Ltd Compounds
TW200406413A (en) 2002-06-26 2004-05-01 Glaxo Group Ltd Compounds
TW200427688A (en) 2002-12-18 2004-12-16 Glaxo Group Ltd Antibacterial agents
EP1471063A1 (en) * 2003-02-28 2004-10-27 Exonhit Therapeutics S.A. Compounds and methods of treating cell proliferative diseases, retinopathies and arthritis
MY150958A (en) * 2005-06-16 2014-03-31 Astrazeneca Ab Compounds for the treatment of multi-drug resistant bacterial infections
US20070185153A1 (en) * 2005-12-22 2007-08-09 Nathalie Cailleau Compounds
ATE481406T1 (de) * 2006-04-06 2010-10-15 Glaxo Group Ltd Pyrrolochinoxalinonderivate als antibakterielle mittel
NZ573032A (en) 2006-05-26 2010-12-24 Taisho Pharmaceutical Co Ltd Antimicrobial heretocyclic compound and intermediates for its production
EP1992628A1 (en) * 2007-05-18 2008-11-19 Glaxo Group Limited Derivatives and analogs of N-ethylquinolones and N-ethylazaquinolones
NZ573644A (en) * 2006-07-20 2011-09-30 Glaxo Group Ltd Derivatives and analogs of n-ethylquinolones and n-ethylazaquinolones

Also Published As

Publication number Publication date
PL2221309T3 (pl) 2013-12-31
WO2009069589A1 (ja) 2009-06-04
CA2706929A1 (en) 2009-06-04
JP5491195B2 (ja) 2014-05-14
EP2221309B1 (en) 2013-07-24
SI2221309T1 (sl) 2013-10-30
AU2008330725B2 (en) 2013-05-30
CY1114936T1 (el) 2016-12-14
BRPI0820394A2 (pt) 2015-05-19
DK2221309T3 (da) 2013-10-07
EP2221309A1 (en) 2010-08-25
HRP20130860T1 (en) 2013-10-11
CN101874032B (zh) 2013-02-06
AU2008330725A1 (en) 2009-06-04
HK1145179A1 (en) 2011-04-08
JPWO2009069589A1 (ja) 2011-04-14
US20100249417A1 (en) 2010-09-30
MX2010005725A (es) 2011-04-11
NZ585529A (en) 2012-05-25
EP2221309A4 (en) 2011-11-09
RU2010126085A (ru) 2012-01-10
CN101874032A (zh) 2010-10-27
KR20100088693A (ko) 2010-08-10
ES2426593T3 (es) 2013-10-24
IL205849A0 (en) 2010-11-30
US8354426B2 (en) 2013-01-15
ZA201003507B (en) 2011-07-27

Similar Documents

Publication Publication Date Title
WO2006028545A3 (en) Substituted imidazoquinolines, imidazopyridines, and imidazonaphthyridines
MXPA05009508A (es) Derivados de nicotinamida 6-substituida como antagonistas de receptor opioide.
EP1225173A4 (en) NAPHTHYRIDINE DERIVATIVES
WO2007106852A3 (en) Substituted fused[1,2]imidazo[4,5-c] ring compounds and methods
WO2008077557A8 (en) 8-ethinylxanthine derivatives as selective a2a receptor antagonists
MY141780A (en) 5-substituted quinoline and isoquinoline derivatives, a method for the production thereof and their use as antiphlogistics
PT2385053E (pt) Intermediários para a preparação de compostos bicíclicos condensados como inibidores mtor
NO20090580L (no) Syklopenta[D]pyrimidiner som AKT-proteinkinaseinhibitorer
ZA200605299B (en) Control of parasites in animals by the use of imidazo [1,2-B]pyridazine derivatives
WO2009017837A3 (en) Sublingual fentanyl spray
WO2006086634A3 (en) Oxime and hydroxylamine substituted imidazo[4,5-c] ring compounds and methods
AU2009258496A8 (en) Sulfur-containing heterocyclic derivative having beta-secretase-inhibiting activity
ZA200707901B (en) Novel imidazo[1,5-a]pyridine derivatives, method for preparing same and pharmaceutical compositions containing same
MX2020008616A (es) Rocio de fentanilo sublingual.
WO2006091567A3 (en) Hydroxyalkyl substituted imidazoquinoline compounds and methods
NZ712378A (en) Synthetic methods for spiro-oxindole compounds
EP1770085A4 (en) DIAMINE DERIVATIVE, PROCESS FOR PRODUCING THE SAME, AND FUNGICIDE CONTAINING THE DERIVATIVE AS ACTIVE INGREDIENT
PT2221309E (pt) Derivado de naftiridina sob a forma de mono-hidrato e processo para o seu fabrico
WO2005105753A8 (en) Naphthalimide derivatives, methods for their production and pharmaceutical compositions therefrom
WO2005021544A3 (en) N3-substituted imidazopyridine-derivatives as c-kit inhibitors
MX2009002715A (es) Metodos para mejorar la funcion cognoscitiva.
NO20080033L (no) Kinolinderivater som NK3-antagonister
NO20065551L (no) Anvendelse av opoid reseptor antagonistforbindelser for forhindring og/eller behandling av sykdommer assosiert med malet calcineurin
WO2007064719A3 (en) Formulations of quinolinones
WO2007039123A3 (en) Combination therapy comprising an nk-3 antagonist and an antipsychotic agent